Block of cardiac sodium channels by amiodarone studied by using Vmax of action potential in single ventricular myocytes

British Journal of Pharmacology
H HonjoJ Toyama

Abstract

1. Acute effects of amiodarone on cardiac sodium channels were investigated in ventricular myocytes isolated from guinea-pig hearts, and compared with those of lignocaine. 2. Transmembrane potential was recorded and controlled by whole-cell current-clamp and voltage-clamp respectively through suction pipette electrodes. The maximum upstroke velocity (Vmax) of the action potential was used as a qualitative index of sodium channel availability. 3. In myocytes treated with amiodarone (1 microM) or lignocaine (40 microM), Vmax of reference action potential elicited at 0.03 Hz was decreased by 6-11%, indicating minimal tonic block of sodium channels. 4. Application of a single conditioning depolarization to those myocytes resulted in a significant decrease in Vmax of a subsequent test action potential. The Vmax reduction was enhanced in a single exponential function as the clamp pulse duration was prolonged. Time constants at 0 mV clamp were 25 ms for amiodarone and 122 ms for lignocaine. 5. Vmax recovery of test action potential following a 1000 ms 0 mV clamp was approximated by a dual exponential function. Time constants for the late slow component (tau R) at the resting potential level were 418 ms for amiodarone and 178 ms for li...Continue Reading

References

Jan 15, 1976·Biochemical Pharmacology·P Polster, J Broekhuysen
Aug 1, 1988·Circulation Research·M F SheetsH A Fozzard
May 1, 1985·American Heart Journal·E A RaederB Lown
Feb 19, 1987·The New England Journal of Medicine·J W Mason
Aug 13, 1987·The New England Journal of Medicine
May 1, 1985·Journal of the American College of Cardiology·S M YabekB N Singh
Jun 19, 1985·European Journal of Pharmacology·A VarroB Surawicz
Aug 1, 1970·British Journal of Pharmacology·B N Singh, E M Vaughan Williams
Oct 1, 1984·Circulation Research·A O GrantH C Strauss
Apr 1, 1984·Journal of Clinical Pharmacology·E M Vaughan Williams
Jan 1, 1984·Annual Review of Pharmacology and Toxicology·L M Hondeghem, B G Katzung
Jan 1, 1983·Circulation·L HarrisD M Krikler
Jan 1, 1983·Pflügers Archiv : European journal of physiology·J W MasonB G Katzung
Jul 1, 1982·Pflügers Archiv : European journal of physiology·T Saikawa, E Carmeliet
Oct 1, 1982·Pflügers Archiv : European journal of physiology·G Isenberg, U Klockner
Nov 1, 1980·Biophysical Journal·L Ebihara, E A Johnson
Aug 1, 1980·Acta Anaesthesiologica Scandinavica·P H Rosenberg, J E Heavner

❮ Previous
Next ❯

Citations

Aug 1, 1995·Pflügers Archiv : European journal of physiology·H WindischD Platzer
Dec 12, 2007·Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology·Christopher R DeWittKennon Heard
Nov 24, 1999·The American Journal of Cardiology·I KodamaJ Toyama
Oct 24, 1998·Progress in Biophysics and Molecular Biology·E Carmeliet, K Mubagwa
Jun 26, 2002·Journal of Veterinary Pharmacology and Therapeutics·S BicerR L Hamlin
Nov 2, 2014·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Michael R FranzSteven N Singh
Jan 27, 1992·Annals of the New York Academy of Sciences·I KodamaJ Toyama
Apr 29, 2003·Journal of Cardiovascular Electrophysiology·Luc M HondeghemFred De Clerck
Aug 2, 2003·Journal of Cardiovascular Electrophysiology·Nathalie LalevéeSylvain Richard
Oct 10, 2003·The Journal of Pharmacology and Experimental Therapeutics·Toshiaki SatoHaruaki Nakaya

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.